Antibiotic resistance is often the result of mutations that block drug activity; however, bacteria also evade antibiotics by transiently expressing genes such as multidrug efflux pumps. A crucial question is whether transient resistance can promote permanent genetic changes. Previous studies have established that antibiotic treatment can select tolerant cells that then mutate to achieve permanent resistance. Whether these mutations result from antibiotic stress or preexist within the population is unclear. To address this question, we focused on the multidrug pump AcrAB-TolC. Using time-lapse microscopy, we found that cells with higher acrAB expression have lower expression of the DNA mismatch repair gene mutS, lower growth rates, and higher mutation frequencies. Thus, transient antibiotic resistance from elevated acrAB expression can promote spontaneous mutations within single cells.
A ntibiotic resistance is a major public health problem and is primarily the result of genetic changes that allow microorganisms to overcome the effects of antimicrobial drugs (1) . However, genetic changes are not the only way that bacteria can tolerate antibiotics. Transient resistance mechanisms allow cells to temporarily resist drug treatment (2) , playing a critical role in recalcitrant and recurrent infections (3) . Examples include bacterial persistence, where cells temporarily enter a dormant state to block drug activity (4) , and expression of efflux pumps to export antibiotics (5-7). We asked whether transient antibiotic resistance can lead to permanent antibiotic resistance by providing a window of opportunity in which cells can mutate. A recent study showed that bacterial persistence precedes resistance. In this state, tolerant cells can subsequently acquire mutations conferring resistance (8) . Additionally, antibiotics often induce stress response mechanisms, which can lead to mutations. For instance, the low-fidelity, mutation-prone polymerases Pol II, Pol IV, and Pol V are induced during the SOS response to DNA damage (9) . A question remains whether differences in mutation frequency predate antibiotic treatment or whether they are induced by the stress.
We focused on transient resistance arising from heterogeneity in expression of the AcrAB-TolC efflux pump found in many pathogens (6, 7, 10) . The pump recognizes and exports b-lactam, tetracycline, and fluoroquinolone antibiotics, among others (11) , by using the inner membrane protein AcrB, which works together with the periplasmic linker AcrA and the outer membrane channel TolC (10, 12) . acrA and acrB are commonly arranged together on an operon, whereas tolC is expressed elsewhere in the genome.
Recent reports have highlighted the importance of cell-to-cell variability in pump expression (6, 7) . For example, in Escherichia coli, AcrAB-TolC pumps partition heterogeneously, with pumps accumulating at the old pole, resulting in increased resistance levels in the subset of cells with higher efflux pump expression (7) . We asked whether cell-to-cell heterogeneity in pump expression results in differences in the spontaneous mutation rate in addition to its known role in producing single-cell differences in transient antibiotic resistance.
We first calculated the spontaneous mutation frequency in E. coli strains with and without efflux pumps. To identify mutations not induced by stress, we performed these measurements in the absence of antibiotics. We plated midexponential phase cultures on LB agar with and without rifampicin and calculated the mutation fig. S9A . Strains without acrAB overexpression contained an equivalent plasmid expressing cfp in place of acrAB. *P < 0.05; **P < 0.01; ***P < 0.001, Mann-Whitney rank sum test. 
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frequency by dividing the number of colonyforming units (CFU) per milliliter on rifampicin plates by the number of CFU per milliliter on LB plates ( Fig. 1A) (13) .
We first compared wild-type E. coli strains with and without overexpression of the acrAB operon. Although AcrA and AcrB function together with TolC, overexpression of the acrAB operon alone is sufficient to increase resistance (14, 15) . We found that the wild-type strain had a significantly lower mutation frequency than the strain overexpressing acrAB (Fig. 1B) . These mutation frequencies correspond to mutation rates of 1.06 × 10 −8 and 2.84 × 10 −8 mutations per generation in the wild-type and acrAB strains, respectively (table S1), providing resistance without incurring a major fitness cost (16) . Deleting acrB, which inactivates the entire efflux pump (14) , also significantly decreased the mutation frequency relative to that of the wild-type strain (Fig. 1B) . Complementing the DacrB strain with a plasmid containing the acrAB operon restored and further increased the mutation frequency over that of the wild type. Using sequencing, we confirmed that the resistance originated from mutations within the rpoB gene, which is a known target for rifampicin (17) (table S2) . Taken together, these results suggest that elevated expression of the AcrAB efflux pump, which plays a critical role in transient resistance, can also increase the frequency of spontaneous mutations.
We asked whether our findings could be generalized to other bacterial species by focusing on the pathogen Salmonella enterica serovar Typhimurium LT2 (10) . We introduced a plasmid overexpressing acrAB into S. Typhimurium and again observed an increase in the spontaneous mutation frequency (Fig. 1C) .
We also measured mutation frequencies in E. coli DacrB with and without acrAB overexpression by using ciprofloxacin, tetracycline, and chloramphenicol. In each case, we used antibiotic concentrations that exceeded the minimum inhibitory concentration for the strain with acrAB overexpression to ensure that we were measuring the mutation frequency and not differences due to drug efflux (15, 18) (fig. S1 ). Consistent with our results in rifampicin, overexpression of acrAB significantly increased the mutation frequency in all three antibiotics relative to those of the strains lacking the pumps (Fig. 1D) .
To test whether the differences in mutation frequency are due to pump activity, we generated a catalytically compromised mutant expressing acrB with a Phe 610 →Ala (F610A) mutation (19) . In contrast to bacteria with functional AcrB, the DacrB strain complemented with a plasmid containing acrAB F610A had no change in the mutation frequency relative to the DacrB strain ( fig. S2 ), suggesting that pump activity is critical for the mutation rate differences.
MutS is involved in DNA mismatch repair, which is a crucial step in preventing mutations. MutS deficiency leads to a hypermutable phenotype (20) . Recent studies have revealed heterogeneity in the expression of DNA repair enzymes between single cells, highlighting the importance of single-cell-level effects in the emergence of resistance (21) (22) (23) . To study the link between acrAB and mutS expression, we constructed a double-color plasmid to report expression simultaneously from the acrAB and mutS promoters. We fused the acrAB promoter to the gene for red fluorescent protein (RFP) (yielding P acrAB -rfp) and the mutS promoter to the gene for yellow fluorescent protein (YFP) (yielding P mutS -yfp). Using fluorescence microscopy, we observed cell-to-cell variation in both reporters, with cells expressing either P acrAB -rfp or P mutS -yfp but not both (Fig. 2, A and B) . This indicates that cells with higher efflux pump expression, which are more antibiotic resistant (7), also have less mismatch repair, making them more mutation prone (21) .
To check whether this effect is due to AcrAB, we introduced the double-color reporter into the DacrB strain. This decreased the population of cells with high P acrAB and low P mutS expression (Fig. 2, A, C, and D) and potentially indicates positive feedback between AcrAB and its promoter. Complementing the DacrB strain with a plasmid containing acrAB restored cells with higher levels of P acrAB and lower levels of P mutS expression ( fig. S3 ). To rule out spurious plasmid effects as the cause of the inverse relationship, we also tested double-color reporters in which we replaced the P acrAB and P mutS promoters each with a constitutive promoter and no longer observed the reciprocal relationship between the two colors ( fig. S4) .
Transcriptional fusions between promoters and reporters give an indirect measurement of protein levels; therefore, we next sought to verify our findings by using translational fusions of AcrAB and MutS with fluorescent reporters. We observed a similar relationship between AcrAB-RFP and MutS-YFP, with a subset of cells containing higher levels of AcrAB efflux pumps and lower MutS expression (Fig. 2, E and F) .
When we overexpressed acrAB in a DmutS strain, we observed no significant difference in the spontaneous mutation frequency between the strains with and without acrAB overexpression ( fig. S5 ). Because MutS is involved in mutation repair, the overall mutation rate is higher in the DmutS strain than in wild-type cells (24) . The similar mutation frequencies observed with and without acrAB overexpression may be due to the role of MutS as an effector in the AcrABdependent mutation increase, or alternatively, the strong mutator phenotype may simply mask any differences. The AcrAB pump provides transient antibiotic resistance but can be costly to express. Overexpression alters membrane fluidity, slows growth, and can cause cells to pump out essential metabolites (10, 25) . Thus, there is a trade-off between pump expression and fitness (25) . It is well known that mutation rates are dependent on growth rates in E. coli, and mutS expression is repressed in nutritionally stressed cells (26) (27) (28) . We found that the total number of CFU per milliliter decreased when acrAB was overexpressed ( fig. S6) Growth rate (min 
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ΔacrB Fig. 3 . Reduced growth rate in single cells with high P acrAB and low P mutS expression. (A) Time-lapse microscopy images of wild-type cells expressing P acrAB -rfp + P mutS -yfp. Scale bar, 2 mm. (B) P acrAB -rfp expression versus P mutS -yfp expression in the wild-type strain. The purple dots correspond to cells whose growth rate falls in the bottom 10% of those measured.
(C) P acrAB -rfp expression and (D) P mutS -yfp expression versus the growth rate in the wild-type strain. (E) DacrB cells expressing P acrAB -rfp and P mutS -yfp.
(F) P acrAB -rfp expression versus P mutS -yfp expression in DacrB cells. and low P mutS expression grew more slowly than those with low P acrAB and high P mutS expression ( Fig. 3A and movie S1 ). We quantified P acrAB and P mutS expression and growth rates across many growing microcolonies (n = 3213 cells) and again observed an inverse relationship between P acrAB expression and P mutS expression (Fig. 3B) . Overlaying the growth rate onto these data, we found that the slowest-growing cells were those with high P acrAB and low P mutS expression (Fig. 3, B  to D) . Measurements with the AcrAB-RFP and MutS-YFP translational fusion strain also showed slower growth in this subpopulation of cells ( fig. S7 and movie S2) .
Growth rate-dependent effects disappeared in a DacrB background, with cells growing at similar rates across all levels of P acrAB expression ( Fig. 3E and movie S3) . Quantification across microcolonies confirmed this finding, and growth rates were roughly constant, regardless of P acrAB or P mutS expression (Fig. 3, F to H) .
Together, these results demonstrate that acrAB expression affects single-cell growth rates and that cell-to-cell differences in pump expression result in a subpopulation of cells with high P acrAB expression, low P mutS expression, and a low growth rate.
The AcrAB efflux pump is regulated by the transcription factor MarA (29) . Mutations in marA and its regulator marR frequently arise in clinical isolates and antibiotic resistance studies (30, 31) . In addition, MarA expression is heterogeneous and dynamic within isogenic single cells, and its stochastic expression is associated with elevated transient resistance (5, 32) . Using fluorescence-activated cell sorting, we found that cells with higher marA expression were more mutation prone than those with low marA expression and that this effect was due predominantly to the AcrAB pump ( fig. S8 and supplementary text) .
These results demonstrate a link between transient resistance and heterogeneity in spontaneous mutation frequencies. Our findings indicate that the AcrAB efflux pump, which plays a known role in multidrug resistance, can also affect the initial stages of the evolution of permanent antibiotic resistance. Our results suggest that heterogeneity in AcrAB is correlated with expression of the mismatch repair enzyme MutS in individual cells and that elevated levels of acrAB expression decrease the growth rate. In our work, this role for AcrAB was shown in the absence of antibiotic stress, so these differences in mutation frequency are not induced by antibiotic treatment.
Even modest increases in the mutation rate can drive the evolution of resistance under selective pressure. For instance, weak mutator phenotypes have been shown to play a critical role in the evolution of resistance to ciprofloxacin in E. coli and Staphylococcus aureus (16, 33) . Achieving resistance to clinical levels of antibiotics is often a multistep process, requiring several mutational events. As an example, acrAB-related genes, including the regulators acrR, marR, soxR, and marA, appeared frequently in a microbial evolution and growth arena (MEGA)-plate study in which E. coli evolved resistance to trimethoprim (30) .
Our findings open the door for further studies of the molecular mechanism by which AcrAB affects mutation frequency. Mutation rates have been shown to depend on the cell growth rate and population density (26, 27) . Given the link between pump expression and growth, it is likely that other growth-related phenomena are influenced by single-cell-level differences in pump expression. Efflux pumps may contribute to increases in the mutation rate by influencing growth alone or by exporting compounds involved in cell-to-cell interactions and the methyl cycle (13) . Multidrug efflux pumps and DNA repair enzymes are widespread (20, 34, 35) . Understanding the initial evolutionary trajectory of resistant strains may suggest strategies for treating infections, such as combination therapies involving antibiotics and efflux pump inhibitors (36) .
